Explore how analytical measurements and flow cytometry support the development, manufacturing, and clinical evaluation of cellular therapies.

This expert insight examines the critical role of analytical testing throughout the cell therapy lifecycle, from product characterization and manufacturing to post-infusion monitoring. Learn how context of use drives assay selection, why accurate cell counting and immunophenotyping are essential, and how advances in spectral flow cytometry are improving the characterization and monitoring of cell therapies such as CAR T cells.

Key topics include:

• The importance of context of use in selecting analytical methods for cell therapy development
• How flow cytometry supports cell therapy manufacturing, product characterization, and quality assessment
• Best practices for cell enumeration, immunophenotyping, and post-infusion monitoring of cellular therapies
• The advantages of high-parameter spectral flow cytometry for generating reliable, clinically meaningful data

As cellular therapies continue to advance, robust analytical strategies are essential for generating reliable data that support product quality, patient monitoring, and clinical decision-making. Discover how flow cytometry and fit-for-purpose analytical measurements are helping drive the next generation of cell therapy development.